Kathrin Blagec

1.1k total citations
15 papers, 329 citations indexed

About

Kathrin Blagec is a scholar working on Pharmacology, Artificial Intelligence and Molecular Biology. According to data from OpenAlex, Kathrin Blagec has authored 15 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Artificial Intelligence and 4 papers in Molecular Biology. Recurrent topics in Kathrin Blagec's work include Pharmacogenetics and Drug Metabolism (8 papers), Biomedical Text Mining and Ontologies (4 papers) and Statistical Methods in Clinical Trials (4 papers). Kathrin Blagec is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Biomedical Text Mining and Ontologies (4 papers) and Statistical Methods in Clinical Trials (4 papers). Kathrin Blagec collaborates with scholars based in Austria, United States and United Kingdom. Kathrin Blagec's co-authors include Matthias Samwald, Richard D. Boyce, Hong Xu, Sebastian J. Hofer, Adriano Barbosa-Silva, Daniel C. Malone, Georg Dorffner, Philip E. Empey, Patrick Ryan and Jesse J. Swen and has published in prestigious journals such as Nature Communications, PLoS ONE and BMC Bioinformatics.

In The Last Decade

Kathrin Blagec

15 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathrin Blagec Austria	12	180	97	67	44	43	15	329
Jim Jirjis United States	6	235 1.3×	110 1.1×	34 0.5×	125 2.8×	97 2.3×	12	445
Marios A. G. Viana United States	9	147 0.8×	18 0.2×	25 0.4×	30 0.7×	41 1.0×	17	324
Michael K. Smith United States	11	53 0.3×	61 0.6×	16 0.2×	33 0.8×	42 1.0×	31	551
Peter Speltz United States	7	50 0.3×	8 0.1×	155 2.3×	64 1.5×	157 3.7×	11	398
John Kilbourne United States	6	29 0.2×	10 0.1×	124 1.9×	37 0.8×	193 4.5×	10	386
Kelly Zeng United States	7	29 0.2×	9 0.1×	130 1.9×	37 0.8×	193 4.5×	12	383
Brian McCourt United States	6	14 0.1×	32 0.3×	25 0.4×	26 0.6×	94 2.2×	8	585
Fleur Mougin France	13	17 0.1×	19 0.2×	240 3.6×	17 0.4×	270 6.3×	52	484
Stephanie J. Reisinger United States	9	12 0.1×	24 0.2×	40 0.6×	5 0.1×	80 1.9×	10	322
Andrew J. Zimolzak United States	9	23 0.1×	14 0.1×	58 0.9×	9 0.2×	25 0.6×	23	228

Countries citing papers authored by Kathrin Blagec

Since Specialization

Citations

This map shows the geographic impact of Kathrin Blagec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Blagec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Blagec more than expected).

Fields of papers citing papers by Kathrin Blagec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Blagec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Blagec. The network helps show where Kathrin Blagec may publish in the future.

Co-authorship network of co-authors of Kathrin Blagec

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Blagec. A scholar is included among the top collaborators of Kathrin Blagec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Blagec. Kathrin Blagec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Blagec, Kathrin, et al.. (2022). A global analysis of metrics used for measuring performance in natural language processing. 52–63. 14 indexed citations

Blagec, Kathrin, et al.. (2022). Benchmark datasets driving artificial intelligence development fail to capture the needs of medical professionals. Journal of Biomedical Informatics. 137. 104274–104274. 20 indexed citations

Barbosa-Silva, Adriano, et al.. (2022). Mapping global dynamics of benchmark creation and saturation in artificial intelligence. Nature Communications. 13(1). 6793–6793. 11 indexed citations

Blagec, Kathrin, et al.. (2022). A curated, ontology-based, large-scale knowledge graph of artificial intelligence tasks and benchmarks. Scientific Data. 9(1). 322–322. 27 indexed citations

Blagec, Kathrin, Jesse J. Swen, Rudolf Koopmann, et al.. (2022). Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries. PLoS ONE. 17(6). e0268534–e0268534. 28 indexed citations

Blagec, Kathrin, et al.. (2022). Digital health understanding and preparedness of medical students: a cross-sectional study. Medical Education Online. 27(1). 2114851–2114851. 16 indexed citations

Blagec, Kathrin, et al.. (2018). Fast and scalable neural embedding models for biomedical sentence classification. BMC Bioinformatics. 19(1). 21 indexed citations

Blagec, Kathrin, David Jungwirth, Daniela Haluza, & Matthias Samwald. (2018). Effects of Medical Device Regulations on the Development of Stand-Alone Medical Software: A Pilot Study. Studies in health technology and informatics. 248. 180–187. 1 indexed citations

Blagec, Kathrin, Rudolf Koopmann, Cathelijne H. van der Wouden, et al.. (2018). Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project. Journal of the American Medical Informatics Association. 25(7). 893–898. 59 indexed citations

10.

Blagec, Kathrin, et al.. (2017). The Importance of Gene-Drug-Drug-Interactions in Pharmacogenomics Decision Support: An Analysis Based on Austrian Claims Data. Studies in health technology and informatics. 236. 121–127. 11 indexed citations

11.

Blagec, Kathrin, et al.. (2016). Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study. PeerJ. 4. e1671–e1671. 22 indexed citations

12.

Samwald, Matthias, Hong Xu, Kathrin Blagec, et al.. (2016). Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available. PLoS ONE. 11(10). e0164972–e0164972. 66 indexed citations

13.

Samwald, Matthias, Kathrin Blagec, Sebastian J. Hofer, & Robert R. Freimuth. (2015). Analyzing the Potential for Incorrect Haplotype Calls with Different Pharmacogenomic Assays in Different Populations: A Simulation Based on 1000 Genomes Data. Pharmacogenomics. 16(15). 1713–1721. 11 indexed citations

14.

Miñarro-Giménez, José Antonio, Kathrin Blagec, Richard D. Boyce, Klaus-Peter Adlassnig, & Matthias Samwald. (2014). An Ontology-Based, Mobile-Optimized System for Pharmacogenomic Decision Support at the Point-of-Care. PLoS ONE. 9(5). e93769–e93769. 16 indexed citations

15.

Samwald, Matthias, José Antonio Miñarro-Giménez, Kathrin Blagec, & Klaus-Peter Adlassnig. (2014). Towards a Global IT System for Personalized Medicine: the Medicine Safety Code Initiative. Studies in health technology and informatics. 198. 25–31. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact